Hiral D. Parekh

Clinicopathological and Molecular Characteristics of Early-Onset Stage III Colon Adenocarcinoma: An Analysis of the ACCENT Database

Zhaohui Jin, Jesse G. Dixon, Jack Fiskum et al. · JNCI Journal of the National Cancer Institute · 2021 · 44 citations · Full text

Medicine, Oncology, Pathology +17

Disseminated Fusariosis Occurring in Two Patients Despite Posaconazole Prophylaxis

Prithviraj Bose, Hiral D. Parekh, Jennifer Holter‐Chakrabarty et al. · Journal of Clinical Microbiology · 2011 · 21 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Extragastrointestinal stromal tumors of the pelvic cavity and the vagina: Two case reports and review of the literature

Wissam Hanayneh, Jason S. Starr, Thomas J. George et al. · Gynecologic Oncology Reports · 2018 · 21 citations · Full text

Medicine, Oncology, Pathology +11

Active Smoking Is Associated With Worse Prognosis in Metastatic Renal Cell Carcinoma Patients Treated With Targeted Therapies

Nils Kroeger, Haoran Li, Guillermo de Velasco et al. · Clinical Genitourinary Cancer · 2018 · 15 citations

Medicine, Nephrology, Oncology +12

Phase II trial of the PARP inhibitor, niraparib, in BAP1 and other DNA damage response (DDR) pathway deficient neoplasms including cholangiocarcinoma.

Thomas J. George, David L. DeRemer, Hiral D. Parekh et al. · Journal of Clinical Oncology · 2020 · 14 citations

Medicine, Molecular Biology, Oncology +17